With Eli Lil­ly's back­ing, a team of Seagen vet­er­ans with ADC chops is look­ing to crash the Chi­nese on­col­o­gy par­ty

With an in­dus­try­wide pipeline quick­ly gath­er­ing steam, the Chi­nese on­col­o­gy mar­ket has be­come a red-hot mar­ket for West­ern in­vestors as well as Big Phar­ma part­ners …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER